PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 290.0
(-1.36%)
IDR 290.0
(-1.36%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 53.77 Billion IDR | 32.98% |
| 2022 | 40.43 Billion IDR | 5.27% |
| 2021 | 38.41 Billion IDR | 202.91% |
| 2020 | 12.68 Billion IDR | -5.45% |
| 2019 | 13.41 Billion IDR | -54.78% |
| 2018 | 29.66 Billion IDR | 55.01% |
| 2017 | 19.13 Billion IDR | 22.55% |
| 2016 | 15.61 Billion IDR | 52.55% |
| 2015 | 10.23 Billion IDR | 35.74% |
| 2014 | 7.54 Billion IDR | -3.83% |
| 2013 | 7.84 Billion IDR | -2.38% |
| 2012 | 8.03 Billion IDR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 49.21 Billion IDR | -15.76% |
| 2024 Q3 | 49.64 Billion IDR | 0.88% |
| 2024 Q1 | 58.42 Billion IDR | 8.64% |
| 2023 Q1 | 43.12 Billion IDR | 6.64% |
| 2023 FY | 53.77 Billion IDR | 32.98% |
| 2023 Q2 | 51.72 Billion IDR | 19.94% |
| 2023 Q4 | 53.77 Billion IDR | 9.29% |
| 2023 Q3 | 49.2 Billion IDR | -4.87% |
| 2022 Q1 | 35.27 Billion IDR | -8.17% |
| 2022 Q2 | 34.71 Billion IDR | -1.6% |
| 2022 FY | 40.43 Billion IDR | 5.27% |
| 2022 Q3 | 35.85 Billion IDR | 3.31% |
| 2022 Q4 | 40.43 Billion IDR | 12.76% |
| 2021 Q4 | 38.41 Billion IDR | 54.11% |
| 2021 Q2 | 17.47 Billion IDR | 57.5% |
| 2021 Q1 | 11.09 Billion IDR | -12.52% |
| 2021 FY | 38.41 Billion IDR | 202.91% |
| 2021 Q3 | 24.92 Billion IDR | 42.66% |
| 2020 Q3 | 10.33 Billion IDR | 0.02% |
| 2020 FY | 12.68 Billion IDR | -5.45% |
| 2020 Q2 | 10.33 Billion IDR | -37.82% |
| 2020 Q4 | 12.68 Billion IDR | 22.7% |
| 2020 Q1 | 16.61 Billion IDR | 23.9% |
| 2019 Q3 | 13.27 Billion IDR | -38.46% |
| 2019 FY | 13.41 Billion IDR | -54.78% |
| 2019 Q4 | 13.41 Billion IDR | 1.02% |
| 2019 Q2 | 21.57 Billion IDR | -49.12% |
| 2019 Q1 | 42.39 Billion IDR | 42.93% |
| 2018 Q1 | 23.18 Billion IDR | 21.15% |
| 2018 FY | 29.66 Billion IDR | 55.01% |
| 2018 Q4 | 29.66 Billion IDR | 18.12% |
| 2018 Q3 | 25.11 Billion IDR | 5.49% |
| 2018 Q2 | 23.8 Billion IDR | 2.67% |
| 2017 Q1 | 15.5 Billion IDR | -0.72% |
| 2017 Q2 | 18.12 Billion IDR | 16.91% |
| 2017 FY | 19.13 Billion IDR | 22.55% |
| 2017 Q3 | 18.5 Billion IDR | 2.1% |
| 2017 Q4 | 19.13 Billion IDR | 3.42% |
| 2016 FY | 15.61 Billion IDR | 52.55% |
| 2016 Q4 | 15.61 Billion IDR | 18.3% |
| 2016 Q3 | 13.19 Billion IDR | -11.46% |
| 2016 Q2 | 14.9 Billion IDR | 31.61% |
| 2016 Q1 | 11.32 Billion IDR | 10.66% |
| 2015 Q2 | 9.35 Billion IDR | 23.79% |
| 2015 FY | 10.23 Billion IDR | 35.74% |
| 2015 Q1 | 7.55 Billion IDR | 0.24% |
| 2015 Q4 | 10.23 Billion IDR | 11.9% |
| 2015 Q3 | 9.14 Billion IDR | -2.24% |
| 2014 Q4 | 7.54 Billion IDR | -14.82% |
| 2014 Q1 | 6.89 Billion IDR | -12.03% |
| 2014 Q3 | 8.85 Billion IDR | -9.88% |
| 2014 FY | 7.54 Billion IDR | -3.83% |
| 2014 Q2 | 9.82 Billion IDR | 42.4% |
| 2013 Q4 | 7.84 Billion IDR | 9.56% |
| 2013 Q2 | 7.78 Billion IDR | -2.85% |
| 2013 Q1 | 8.01 Billion IDR | -0.28% |
| 2013 FY | 7.84 Billion IDR | -2.38% |
| 2013 Q3 | 7.15 Billion IDR | -8.03% |
| 2012 FY | 8.03 Billion IDR | 0.0% |
| 2012 Q4 | 8.03 Billion IDR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PT Bundamedik Tbk | 42.19 Billion IDR | -27.43% |
| PT Metro Healthcare Indonesia Tbk | 4.77 Billion IDR | -1025.34% |
| PT Medikaloka Hermina Tbk | 117.43 Billion IDR | 54.208% |
| PT Mitra Keluarga Karyasehat Tbk | 81.72 Billion IDR | 34.198% |
| PT Murni Sadar Tbk | 32.12 Billion IDR | -67.373% |
| PT Famon Awal Bros Sedaya Tbk | 54.16 Billion IDR | 0.723% |
| PT Royal Prima Tbk | 54.57 Billion IDR | 1.469% |
| PT Kedoya Adyaraya Tbk | 14.58 Billion IDR | -268.634% |
| PT Siloam International Hospitals Tbk | 203.57 Billion IDR | 73.586% |
| PT Sejahteraraya Anugrahjaya Tbk | 48.94 Billion IDR | -9.876% |